Björn Dahlbäck
71 – 80 of 274
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus
(
- Contribution to journal › Article
-
Mark
Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes
(
- Contribution to journal › Article
-
Mark
Growth arrest specific protein 6 (gas6) and its receptors expression and signalling in beta cells
2010) 46th Annual Meeting of the European-Association-for-the- Study-of-Diabetes (EASD) In Diabetologia 53(Suppl. 1). p.530-530(
- Contribution to journal › Published meeting abstract
-
Mark
Mouse ApoM Displays an Unprecedented Seven-Stranded Lipocalin Fold: Folding Decoy or Alternative Native Fold?
(
- Contribution to journal › Article
-
Mark
Umbilical cord plasma levels of growth-arrest specific protein 6 in intrauterine growth restriction
(
- Contribution to journal › Article
-
Mark
The D2194G mutation is responsible for increased levels of FV1 in carriers of the factor V R2 haplotype
(
- Contribution to journal › Letter
-
Mark
Plasma concentrations of apolipoproteins A-I, B, and M in patients with critical limb ischemia.
(
- Contribution to journal › Article
-
Mark
The role of phospholipid transfer protein in lipoprotein-mediated neutralization of the procoagulant effect of anionic liposomes.
(
- Contribution to journal › Article
-
Mark
Plasma concentrations of Gas6 and soluble Axl correlate with disease and predict mortality in patients with critical limb ischemia.
(
- Contribution to journal › Article
-
Mark
Opposing Effects of Apolipoprotein M on Catabolism of Apolipoprotein B-Containing Lipoproteins and Atherosclerosis.
(
- Contribution to journal › Article